Refining Lung Cancer Diagnosis and Staging with Bronchoscopy and EBUS-TBNA: Evidence from a Regional Romanian Study
<i>Background</i>: Lung cancer remains the leading cause of cancer-related mortality worldwide. Timely and accurate diagnosis and staging are crucial for treatment decisions. <i>Objective</i>: To assess the feasibility, safety, and diagnostic/staging yield of a bronchoscopy-based pathway supported by EBUS-TBNA in a regional Romanian center. Bronchoscopy combined with endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) may reduce the need for surgical confirmation, yet its implementation in regional centers is inconsistent. <i>Materials and Methods</i>: This retrospective study included 67 patients with suspected lung cancer evaluated at a regional oncology center between December 2023 and February 2024. All patients underwent bronchoscopy, and EBUS-TBNA was performed in those with mediastinal lymphadenopathy on imaging, with endoscopic tissue biopsies (endobronchial/EBUS-TBNA). Demographic, clinical, histological, and molecular data were collected and analyzed using descriptive statistics and chi-square/Fisher's exact tests. <i>Results</i>: Among the 67 patients, 42 (62.7%) underwent EBUS-TBNA. The majority were diagnosed in advanced stages (stage III-IV: 83.6%), with adenocarcinoma being the most frequent histological subtype. PD-L1 expression was positive in 52.2% of cases, and p63 in 67.2%. No significant procedural complications occurred, and adequate tissue sampling for histopathological and molecular analyses was achieved in all cases. Associations were found between PD-L1 and advanced TNM stage (<i>p</i> = 0.026), as well as between p63 status and TNM stage (<i>p</i> = 0.002). <i>Conclusions</i>: This study supports the feasibility and safety of a bronchoscopy-based diagnostic and staging algorithm supported by EBUS-TBNA, achieving reliable sampling and avoiding surgical confirmation in a regional oncology setting. Further prospective studies are warranted to validate these findings.
Authors
- Corina Eugenia Budin (ORCID: https://orcid.org/0000-0002-7785-0121)
- Veronica Manolache (ORCID: https://orcid.org/0000-0002-0025-8795)
- Nina Ionovici
- Virginia Maria Rădulescu (ORCID: https://orcid.org/0000-0001-9028-7583)
- Daniela Zob (ORCID: https://orcid.org/0000-0003-1915-1493)
- Natalia Motaș (ORCID: https://orcid.org/0000-0001-6556-3734)
- Viorel Biciuşcă (ORCID: https://orcid.org/0000-0002-9451-6969)
- Florentina Dumitrescu
- Marius Gabriel Bunescu (ORCID: https://orcid.org/0000-0003-4504-4691)
- Mihai Olteanu (ORCID: https://orcid.org/0000-0002-3338-8107)
- Ramona Cioboată (ORCID: https://orcid.org/0009-0006-6335-1627)
- Gabriela Marina Andrei
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Medicine and Pharmacy of Craiova (RO)
- Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
- Institutul Oncologic Bucuresti (RO)
- University of Craiova (RO)
Publication Details
- Journal
- Medicina
- Published
- 2025-08-26
- DOI
- https://doi.org/10.3390/medicina61091528
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52